.Merck defeats incomes desires, rears sales expectation on solid requirement for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Forecasts as Keytruda Purchases Rise BloombergMerck Sell: Pharma Giant Posts Sturdy Results, Yet Outlook Drops Short Investor's Business DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats profit as well as sales desires amidst Keytruda advantage, but offers blended full-year overview MarketWatch.